Market Cap 3.84M
Revenue (ttm) 10,000.00
Net Income (ttm) -4.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -46,800.00%
Debt to Equity Ratio 0.00
Volume 12,600
Avg Vol 599,566
Day's Range N/A - N/A
Shares Out 1.60M
Stochastic %K 18%
Beta -0.74
Analysts Strong Buy
Price Target $3.00

Latest News on TCRT

Alaunos Therapeutics Still Waiting For Home Run

Nov 21, 2022, 2:13 PM EST - 2 years ago

Alaunos Therapeutics Still Waiting For Home Run


Alaunos Therapeutics - T-Cell Therapies

Sep 14, 2022, 9:28 PM EDT - 2 years ago

Alaunos Therapeutics - T-Cell Therapies


CellChorus Announces Scientific Advisory Board

Jun 1, 2022, 11:39 AM EDT - 3 years ago

CellChorus Announces Scientific Advisory Board


Ziopharm Rebrands As Alaunos Therapeutics

Jan 26, 2022, 11:19 AM EST - 3 years ago

Ziopharm Rebrands As Alaunos Therapeutics